Roche Diagnostics Corporation Confirm Anti-C-Met (Sp44) Rbmab

Roche Diagnostics Corporation confirm anti-c-met (sp44) rbmab; ventana medical systems, inc. (ventana) confirm anti-total c-met (sp44) rabbit monoclonal primary antibody is directed against a membranous and/or cytoplasmic epitope present in human normal epithelial or tumor cells. this antibody may be used to aid in the identification of normal and neoplastic c-met expressing cells. the antibody is intended for qualitative staining in sections of formalin fixed, paraffin embedded tissue. the clinical interpretation of any staining, or the absence of staining, must be complemented by histological studies and evaluation of proper controls. evaluation must be made by a qualified pathologist within the context of the patients clinical history and other diagnostic tests. this antibody is intended for in vitro diagnostic (ivd) use. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)